Connection

Terry Day to Head and Neck Neoplasms

Back to Details
This is a "connection" page, showing publications Terry Day has written about Head and Neck Neoplasms.
Terry Day
Connection Strength
11.526
Head and Neck Neoplasms
  1. Trismus intra-operative release and expansion (TIRE): A novel operative treatment for trismus. Head Neck. 2023 03; 45(3):578-585.
    View in: PubMed
    Score: 0.554
  2. Intraoperative vasopressors in head and neck free flap reconstruction. Microsurgery. 2021 Jan; 41(1):5-13.
    View in: PubMed
    Score: 0.478
  3. Predictive value of computed tomography in identifying extranodal extension in human papillomavirus-positive versus human papillomavirus-negative head and neck cancer. Head Neck. 2020 09; 42(9):2687-2695.
    View in: PubMed
    Score: 0.464
  4. Head and neck cancer care in the COVID-19 pandemic: A brief update. Oral Oncol. 2020 06; 105:104738.
    View in: PubMed
    Score: 0.460
  5. Impact of PD-L1 expression and human papillomavirus status in anti-PD1/PDL1 immunotherapy for head and neck squamous cell carcinoma-Systematic review and meta-analysis. Head Neck. 2020 04; 42(4):774-786.
    View in: PubMed
    Score: 0.447
  6. Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review. JAMA Otolaryngol Head Neck Surg. 2019 02 01; 145(2):166-177.
    View in: PubMed
    Score: 0.423
  7. Evaluation of a survivorship needs assessment planning tool for head and neck cancer survivor-caregiver dyads. J Cancer Surviv. 2019 02; 13(1):117-129.
    View in: PubMed
    Score: 0.422
  8. Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial. Clin Cancer Res. 2019 02 15; 25(4):1156-1164.
    View in: PubMed
    Score: 0.417
  9. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer. Cancer. 2017 Dec 15; 123(24):4841-4850.
    View in: PubMed
    Score: 0.383
  10. Adherence to National Comprehensive Cancer Network guidelines for time to initiation of postoperative radiation therapy for patients with head and neck cancer. Cancer. 2017 Jul 15; 123(14):2651-2660.
    View in: PubMed
    Score: 0.370
  11. Effect of postoperative radiotherapy on survival for surgically managed pT3N0 and pT4aN0 laryngeal cancer: Analysis of the National Cancer Data Base. Cancer. 2017 Jun 15; 123(12):2248-2257.
    View in: PubMed
    Score: 0.369
  12. Quality of Life in Head and Neck Cancer Patient-Caregiver Dyads: A Systematic Review. Cancer Nurs. 2016 May-Jun; 39(3):238-50.
    View in: PubMed
    Score: 0.350
  13. Intraoperative goal-directed hemodynamic management in free tissue transfer for head and neck cancer. Head Neck. 2016 04; 38 Suppl 1:E1974-80.
    View in: PubMed
    Score: 0.344
  14. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral Oncol. 2015 Aug; 51(8):727-30.
    View in: PubMed
    Score: 0.328
  15. The ultimate constant of head and neck oncology?the physician-patient relationship. JAMA Otolaryngol Head Neck Surg. 2014 Dec; 140(12):1218-24.
    View in: PubMed
    Score: 0.317
  16. Management of radiotherapy-induced salivary hypofunction and consequent xerostomia in patients with oral or head and neck cancer: meta-analysis and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 May; 117(5):595-607.
    View in: PubMed
    Score: 0.299
  17. Salivary gland transfer to prevent radiation-induced xerostomia: a systematic review and meta-analysis. Oral Oncol. 2014 Feb; 50(2):77-83.
    View in: PubMed
    Score: 0.294
  18. mTOR inhibitors and its role in the treatment of head and neck squamous cell carcinoma. Curr Treat Options Oncol. 2012 Mar; 13(1):71-81.
    View in: PubMed
    Score: 0.262
  19. Head and neck cancer recurrence and mortality in nonselective cyclooxygenase inhibitor users. Arch Otolaryngol Head Neck Surg. 2007 Jan; 133(1):28-31.
    View in: PubMed
    Score: 0.183
  20. Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma. Cancer Immunol Immunother. 2007 Jul; 56(7):1077-86.
    View in: PubMed
    Score: 0.181
  21. Prevention of head and neck cancer. Curr Oncol Rep. 2005 Mar; 7(2):145-53.
    View in: PubMed
    Score: 0.161
  22. Melanoma of the head and neck. Curr Treat Options Oncol. 2005 Jan; 6(1):19-30.
    View in: PubMed
    Score: 0.159
  23. Safety of microvascular free tissue transfer reconstruction of the head and neck in the setting of chronic pharmacologic immunosuppression. Head Neck. 2022 07; 44(7):1520-1527.
    View in: PubMed
    Score: 0.132
  24. A 2020 Update on Public Awareness of Head and Neck Cancers. Otolaryngol Head Neck Surg. 2022 02; 166(2):305-312.
    View in: PubMed
    Score: 0.123
  25. Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer. JCO Oncol Pract. 2021 10; 17(10):e1512-e1523.
    View in: PubMed
    Score: 0.122
  26. Microscopic Extranodal Extension in HPV-Negative Head and Neck Cancer and the Role of Adjuvant Chemoradiation. Otolaryngol Head Neck Surg. 2021 10; 165(4):536-549.
    View in: PubMed
    Score: 0.122
  27. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2020 12 01; 146(12):1109-1119.
    View in: PubMed
    Score: 0.120
  28. Barriers to the Delivery of Timely, Guideline-Adherent Adjuvant Therapy Among Patients With Head and Neck Cancer. JCO Oncol Pract. 2020 12; 16(12):e1417-e1432.
    View in: PubMed
    Score: 0.118
  29. Validation of a Novel, Multidomain Head and Neck Cancer Appearance- and Function-Distress Patient-Reported Outcome Measure. Otolaryngol Head Neck Surg. 2020 11; 163(5):979-985.
    View in: PubMed
    Score: 0.116
  30. The role of head and neck cancer advocacy organizations during the COVID-19 pandemic. Head Neck. 2020 Jul; 42(7):1526-1532.
    View in: PubMed
    Score: 0.116
  31. Evaluation of a novel telemedicine-based intervention to manage body image disturbance in head and neck cancer survivors. Psychooncology. 2020 12; 29(12):1988-1994.
    View in: PubMed
    Score: 0.116
  32. Association of Medicaid Expansion Under the Affordable Care Act With Stage at Diagnosis and Time to Treatment Initiation for Patients With Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2020 03 01; 146(3):247-255.
    View in: PubMed
    Score: 0.114
  33. Temporal Trajectory of Body Image Disturbance in Patients with Surgically Treated Head and Neck Cancer. Otolaryngol Head Neck Surg. 2020 03; 162(3):304-312.
    View in: PubMed
    Score: 0.113
  34. Targeting mTOR in Head and Neck Cancer-Response. Clin Cancer Res. 2019 11 01; 25(21):6555.
    View in: PubMed
    Score: 0.111
  35. Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Patient-Centered Approach. Otolaryngol Head Neck Surg. 2019 08; 161(2):278-287.
    View in: PubMed
    Score: 0.107
  36. Immune Evasion by Head and Neck Cancer: Foundations for Combination Therapy. Trends Cancer. 2019 04; 5(4):208-232.
    View in: PubMed
    Score: 0.107
  37. Body Image Disturbance in Surgically Treated Head and Neck Cancer Patients: A Prospective Cohort Pilot Study. Otolaryngol Head Neck Surg. 2019 07; 161(1):105-110.
    View in: PubMed
    Score: 0.107
  38. A Systematic Review of Patient-Reported Outcome Measures Assessing Body Image Disturbance in Patients with Head and Neck Cancer. Otolaryngol Head Neck Surg. 2019 06; 160(6):941-954.
    View in: PubMed
    Score: 0.106
  39. Causal attributions and their impact on psychosocial functioning in head and neck cancer patient-caregiver dyads: a preliminary, longitudinal study. Qual Life Res. 2019 Apr; 28(4):1105-1109.
    View in: PubMed
    Score: 0.105
  40. Swallowing Outcomes in Elderly Patients following Microvascular Reconstruction of the Head and Neck. Otolaryngol Head Neck Surg. 2018 08; 159(2):320-327.
    View in: PubMed
    Score: 0.100
  41. Thirty-day readmission in patients undergoing head and neck microvascular reconstruction. Head Neck. 2018 07; 40(7):1366-1374.
    View in: PubMed
    Score: 0.099
  42. Physical and emotional well-being and support in newly diagnosed head and neck cancer patient-caregiver dyads. J Psychosoc Oncol. 2017 Nov-Dec; 35(6):646-665.
    View in: PubMed
    Score: 0.094
  43. Double paddle ulnar perforator free flap in reconstruction of through-and-through and fistulous defects of the head and neck. Laryngoscope. 2017 06; 127(6):1302-1305.
    View in: PubMed
    Score: 0.091
  44. Neutrophil-to-lymphocyte ratio and overall survival in all sites of head and neck squamous cell carcinoma. Head Neck. 2016 04; 38 Suppl 1:E1068-74.
    View in: PubMed
    Score: 0.084
  45. The Validity of Self-reported Recent Smoking in Head and Neck Cancer Surgical Patients. Otolaryngol Head Neck Surg. 2015 Dec; 153(6):990-995.
    View in: PubMed
    Score: 0.083
  46. Tobacco use and surgical outcomes in patients with head and neck cancer. Head Neck. 2016 May; 38(5):700-6.
    View in: PubMed
    Score: 0.082
  47. Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma. J Hematol Oncol. 2014 Sep 27; 7:65.
    View in: PubMed
    Score: 0.078
  48. Perioperative survival of elderly head and neck squamous cell carcinoma patients. Laryngoscope. 2014 Oct; 124(10):2281-6.
    View in: PubMed
    Score: 0.077
  49. Results of a phase II trial of gemcitabine plus doxorubicin in patients with recurrent head and neck cancers: serum C18-ceramide as a novel biomarker for monitoring response. Clin Cancer Res. 2011 Sep 15; 17(18):6097-105.
    View in: PubMed
    Score: 0.063
  50. Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma. Hum Immunol. 2010 Jul; 71(7):659-65.
    View in: PubMed
    Score: 0.058
  51. Low-dose weekly platinum-based chemoradiation for advanced head and neck cancer. Laryngoscope. 2010 Feb; 120(2):236-42.
    View in: PubMed
    Score: 0.057
  52. PET/CT in the assessment of previously treated skull base malignancies. Head Neck. 2010 Jan; 32(1):76-84.
    View in: PubMed
    Score: 0.056
  53. Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers. Head Neck. 2009 Apr; 31(4):493-502.
    View in: PubMed
    Score: 0.053
  54. 1alpha,25-Dihydroxyvitamin D(3) to skew intratumoral levels of immune inhibitory CD34(+) progenitor cells into dendritic cells. Otolaryngol Head Neck Surg. 2009 Feb; 140(2):235-40.
    View in: PubMed
    Score: 0.053
  55. Human papillomavirus and head and neck cancer: a growing concern. J S C Med Assoc. 2008 Dec; 104(8):247-51.
    View in: PubMed
    Score: 0.052
  56. Proximal esophageal stenosis in head and neck cancer patients after total laryngectomy and radiation. ORL J Otorhinolaryngol Relat Spec. 2008; 70(4):229-35.
    View in: PubMed
    Score: 0.050
  57. Radiation dose, driving performance, and cognitive function in patients with head and neck cancer. Radiother Oncol. 2008 May; 87(2):304-7.
    View in: PubMed
    Score: 0.050
  58. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg. 2008 May; 134(5):536-8.
    View in: PubMed
    Score: 0.050
  59. Cranial neuropathy as a presenting sign of recurrent aggressive skin cancer. Dermatol Surg. 2008 Apr; 34(4):483-97.
    View in: PubMed
    Score: 0.049
  60. Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): attenuation of C(18)-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis. Cancer Lett. 2007 Oct 18; 256(1):101-11.
    View in: PubMed
    Score: 0.047
  61. Driving behaviors in patients with head and neck cancer during and after cancer treatment: a preliminary report. Head Neck. 2007 Jul; 29(7):675-81.
    View in: PubMed
    Score: 0.047
  62. Mechanisms of tumor growth and metastasis in head and neck squamous cell carcinoma. Curr Treat Options Oncol. 2007 Jun; 8(3):227-38.
    View in: PubMed
    Score: 0.047
  63. Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma. Cancer Lett. 2007 Apr 18; 248(2):269-79.
    View in: PubMed
    Score: 0.045
  64. Head and neck cancer disparities in South Carolina: descriptive epidemiology, early detection, and special programs. J S C Med Assoc. 2006 Aug; 102(7):192-200.
    View in: PubMed
    Score: 0.044
  65. Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo. J Pharmacol Exp Ther. 2006 Jun; 317(3):1188-99.
    View in: PubMed
    Score: 0.043
  66. IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma. Biochem Biophys Res Commun. 2006 Apr 14; 342(3):851-8.
    View in: PubMed
    Score: 0.043
  67. Pediatric rhabdomyosarcoma of the head and neck. Curr Treat Options Oncol. 2006 Jan; 7(1):13-22.
    View in: PubMed
    Score: 0.043
  68. Inhibition of growth and telomerase activity by novel cationic ceramide analogs with high solubility in human head and neck squamous cell carcinoma cells. Otolaryngol Head Neck Surg. 2005 Jan; 132(1):55-62.
    View in: PubMed
    Score: 0.040
  69. Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J Biol Chem. 2004 Oct 22; 279(43):44311-9.
    View in: PubMed
    Score: 0.039
  70. Referred otalgia in head and neck cancer: a unifying schema. Am J Clin Oncol. 2003 Oct; 26(5):e157-62.
    View in: PubMed
    Score: 0.037
  71. Prognostic factors associated with achieving total oral diet following osteocutaneous microvascular free tissue transfer reconstruction of the oral cavity. Oral Oncol. 2019 11; 98:1-7.
    View in: PubMed
    Score: 0.028
  72. Role of mitomycin in upper digestive tract stricture. Head Neck. 2007 Jan; 29(1):12-7.
    View in: PubMed
    Score: 0.011
  73. Muscle-sparing abdominal free flaps in head and neck reconstruction. Head Neck. 2006 Sep; 28(9):802-7.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.